Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with ...

Roche’s Evrysdi (risdiplam) tablets have been approved by the European Commission (EC) to treat spinal muscular atrophy (SMA) ...

The Japanese biotech behind Eli Lilly’s new blockbuster obesity pill believes it could be used with an anti-muscle wasting ...

European Commission approves Roche’s Evrysdi tablet to treat spinal muscular atrophy: Basel Thursday, June 5, 2025, 09:00 Hrs [IST] Roche announced that the European Commission ...

dvm360 connects veterinarians to essential medical news, veterinary expertise, and insights on pet care products and ...

Already offering the only non-invasive treatment for SMA in liquid form, Roche’s Evrysdi now comes as a tablet.

Panelists discuss how disease progression despite treatment in older patients with spinal muscular atrophy (SMA) may be due to natural aging effects combined with SMA, not necessarily treatment ...

Basel: Roche has announced that the European Commission (EC) has approved a label extension for Evrysdi (risdiplam) to ...

Age affects every type of body tissue, including skin, muscles, bone, and more. Learn about the specific effects of aging on ...

The CRISPR gene editing technology has transformed the research lab, and this powerful tool is now making its way into the clinic... | Cell And Molecular Biology ...

India Today’s OSINT team visually illustrates how each of the seven experiments suggested by Indian principal investigators will help future space exploration ...

Astronaut Shukla is set to spend 14 days aboard the ISS. During his time in the space laboratory, he plans to carry out ...